MapLight Therapeutics Ownership | Who Owns MapLight Therapeutics?

MapLight Therapeutics Ownership Summary

MapLight Therapeutics is owned by 58.29% institutional investors, 53.14% insiders. Novo is the largest institutional shareholder, holding 8.14% of MPLT shares. T. Rowe Price US Small-Cap Core Equity is the top mutual fund, with 1.38% of its assets in MapLight Therapeutics shares.

MPLT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	MapLight Therapeutics	58.29%	53.14%	-11.44%
Sector	Healthcare Stocks	50.50%	12.33%	37.17%
Industry	Biotech Stocks	49.09%	12.06%	38.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Novo	3.69M	8.14%	$132.13M
Fcpm iii services b.v.	3.23M	7.13%	$115.63M
T. rowe price investment management	2.78M	6.14%	$99.70M
Goldman sachs group	1.95M	4.30%	$69.83M
Price t rowe associates inc /md/	1.42M	3.14%	$51.00M
Blackrock funding, inc. /de	1.03M	2.26%	$36.74M
Nan fung group	971.25K	2.15%	$34.81M
Vanguard group	869.67K	2.10%	$15.28M
5am venture management	950.01K	2.10%	$34.05M
Sanofi	912.04K	2.01%	$32.69M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Nan fung group	971.25K	26.47%	$34.81M
Fcpm iii services b.v.	3.23M	15.41%	$115.63M
5am venture management	950.01K	11.83%	$34.05M
Velan capital investment management lp	492.89K	10.76%	$17.67M
Novo	3.69M	7.67%	$132.13M
Pivotal bioventure partners investment advisor	611.45K	7.12%	$21.91M
Sanofi	912.04K	6.12%	$32.69M
Blue owl capital lp	729.93K	3.94%	$26.16M
Superstring capital management lp	125.43K	2.84%	$4.50M
Dafna capital management	171.01K	1.17%	$6.13M

Top Buyers

Holder	Shares	% Assets	Change
Price t rowe associates inc /md/	1.42M	0.01%	1.31M
Vanguard group	869.67K	0.00%	869.67K
Paradigm biocapital advisors lp	685.85K	0.46%	685.85K
Fmr	823.56K	0.00%	619.05K
State street	852.15K	0.00%	513.03K

Top Sellers

Holder	Shares	% Assets	Change
Perceptive advisors	-	-	-550.00K
Vestal point capital, lp	-	-	-420.00K
Adar1 capital management	26.50K	0.04%	-348.41K
Blackrock funding, inc. /de	1.03M	0.00%	-314.60K
Blue owl capital lp	729.93K	3.94%	-276.00K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard group	869.67K	0.00%	869.67K	$15.28M
Paradigm biocapital advisors lp	685.85K	0.46%	685.85K	$24.58M
Capital world investors	415.73K	0.00%	415.73K	$14.90M
Sixth street partners management company	136.82K	0.00%	136.82K	$4.90M
Boxer capital management	75.00K	0.20%	75.00K	$2.69M

Sold Out

Holder	Change
True wealth design	-3.00
Mai capital management	-12.00
Root financial partners	-28.00
Federation des caisses desjardins du quebec	-500.00
Amalgamated bank	-530.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	109	34.57%	26,392,574	6.85%	58	1.96%	62	29.17%	28	115.38%
Mar 31, 2026	28	-62.16%	2,594,337	-88.75%	5	0.19%	16	-78.38%	5	-
Dec 31, 2025	33	-	8,880,682	-	21	-	33	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
T. Rowe Price US Small-Cap Core Equity	625.05K	1.38%	-678.00
T. Rowe Price Small-Cap Stock	625.05K	1.38%	-233.00
T. Rowe Price Small-Cap Value	605.60K	1.34%	-218.42K
Vanguard Morn Total Stk Mkt Idx Investor	552.28K	1.22%	73.70K
Vanguard Total Stock Mkt Idx Inv	552.28K	1.22%	73.70K
State Street® SPDR® S&P® Biotech ETF	490.72K	1.08%	1.13K
T. Rowe Price U.S. SC Value Eq Tr-D	411.66K	0.91%	-2.40K
American Funds SMALLCAP World A	404.39K	0.89%	404.39K
T. Rowe Price Integrated US SmCapGrEq	402.79K	0.89%	402.79K
T. Rowe Price Integrated US Sm Gr Eq	402.79K	0.89%	262.70K

MPLT Ownership FAQ

Who Owns MapLight Therapeutics?

MapLight Therapeutics shareholders are primarily institutional investors at 58.29%, followed by 53.14% insiders and -11.43% retail investors. The average institutional ownership in MapLight Therapeutics's industry, Biotech Stocks , is 49.09%, which MapLight Therapeutics exceeds.

Who owns the most shares of MapLight Therapeutics?

MapLight Therapeutics’s largest shareholders are Novo (3.69M shares, 8.14%), Fcpm iii services b.v. (3.23M shares, 7.13%), and T. rowe price investment management (2.78M shares, 6.14%). Together, they hold 21.41% of MapLight Therapeutics’s total shares outstanding.

Does Blackrock own MapLight Therapeutics?

BlackRock is not among the top 10 institutional shareholders of MapLight Therapeutics.

Who is MapLight Therapeutics’s biggest shareholder by percentage of total assets invested?

Nan fung group is MapLight Therapeutics’s biggest shareholder by percentage of total assets invested, with 26.47% of its assets in 971.25K MapLight Therapeutics shares, valued at 34.81M$.

Who is the top mutual fund holder of MapLight Therapeutics shares?

T. Rowe Price US Small-Cap Core Equity is the top mutual fund holder of MapLight Therapeutics shares, with 1.38% of its total shares outstanding invested in 625.05K MapLight Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools